Effective 5/9/2017 26-55-104. Prescribing, dispensing, and administering an opiate antagonist — Immunity from liability. (1) (a) (i) For purposes of Subsection (1)(a)(ii), “a person other than a health care facility or health care provider” includes the following, regardless of whether the person has received funds from the department through the Opiate Overdose Outreach Pilot Program […]
Effective 5/4/2022 26-55-105. Standing prescription drug orders for an opiate antagonist. (1) Notwithstanding Title 58, Chapter 17b, Pharmacy Practice Act, a person licensed under Title 58, Chapter 17b, Pharmacy Practice Act, to dispense an opiate antagonist may dispense the opiate antagonist: (a) pursuant to a standing prescription drug order made in accordance with Subsection (2); […]
Effective 5/9/2017 26-55-106. Overdose outreach providers. Notwithstanding Sections 58-1-501, 58-17b-501, and 58-17b-502: (1) an overdose outreach provider may: (a) obtain an opiate antagonist dispensed on prescription by: (i) a health care provider, in accordance with Subsections 26-55-104(2) and (3); or (ii) a pharmacist or pharmacy intern, as otherwise authorized by Title 58, Chapter 17b, Pharmacy […]
Effective 1/1/2021 26-55-107. Opiate Overdose Outreach Pilot Program — Grants — Annual reporting by grantees — Rulemaking — Annual reporting by department. (1) As used in this section: (a) “Persons that are in a position to assist an individual who is at increased risk of experiencing an opiate-related drug overdose event”: (i) means the following […]
Effective 5/4/2022 26-55-108. Coprescription guidelines. (1) As used in this section: (a) “Controlled substance prescriber” means the same as that term is defined in Section 58-37-6.5. (b) “Coprescribe” means to issue a prescription for an opiate antagonist with a prescription for an opiate. (2) The department shall, in consultation with the Physicians Licensing Board created […]
Effective 5/8/2018 26-55-109. Opiate abuse prevention pamphlet. (1) As funding is available, the department shall produce and distribute, in conjunction with the Division of Substance Abuse and Mental Health, a pamphlet about opiates that includes information regarding: (a) the risk of dependency and addiction; (b) methods for proper storage and disposal; (c) alternative options for […]
